Bioiberica to exhibit joint health ingredient at Vitafoods Europe

Figures suggest 67% of global consumers recognise a link between mobility and overall health and as many as 31% 25-34 year olds are planning to improve their joint health in the next year

Bioiberica, a global life science company, is set to return to Vitafoods Europe’s in person exhibition in Geneva, 5-7 October. The company will be revealing the results of scientific research on its hyaluronic acid matrix ingredient, Mobilee, for joint health, as well as sharing the latest consumer insights on the mobility market.

The company’s study investigated the bioavailability of the ingredient, and its ability to increase the production of hyaluronic acid in the joints. The company’s R&D team will be available on stand to discuss the results of the study, and what this means for manufacturers in the mobility market.

Figures suggest 67% of global consumers recognise a link between mobility and overall health and as many as 31% 25-34 year olds are planning to improve their joint health in the next year. Bioiberica’s Healthcare Director, Jaume Reguant, and Head of Human Health R&D, Daniel Martínez Puig, PhD will be discussing the opportunities the market presents for brands at this year’s exhibition.

To respond to this evolving market, the company recently introduced an updated look mobility portfolio, bringing its branded ingredients together under a common goal to offer manufacturers a suite of products, made more accessible and identifiable with a clearer brand architecture.

Companies